z-logo
open-access-imgOpen Access
Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
Author(s) -
Monica Ragozzino,
Alfred C. Kuo,
James DeGregori,
Nancy E. Kohl,
H. Earl Ruley
Publication year - 1991
Publication title -
environmental health perspectives
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.257
H-Index - 282
eISSN - 1552-9924
pISSN - 0091-6765
DOI - 10.1289/ehp.919397
Subject(s) - oncogene , biology , transformation (genetics) , function (biology) , antagonist , microbiology and biotechnology , cell growth , gene , antigen , cancer research , immunology , genetics , receptor , cell cycle
Gene transfer experiments have defined limitations with regard to the ability of individual oncogenes to transform cultured cells to a tumorigenic state. The stable transformation of REF52 cells by either the ras or sis oncogenes requires the continuous expression of a second collaborating oncogene, such as adenovirus-5 E1A or SV40 large T-antigen. Our studies suggest that the function of the nuclear collaborators is to antagonize dominant growth controls which limit the ability of REF52 cells to proliferate in response to mitogenic stimuli.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom